1. Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman

    Axcella Announces Appointment of David Epstein, Former CEO of Novartis Pharmaceuticals, as Chairman

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella Health, a biotechnology company pioneering Designed Amino Acid Compositions (DAAC™) as therapeutics across a range of important diseases, announced today that David R. Epstein has been elected as Chairman of its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. David is a tremendous and very timely addition to our Board of Directors, bringing over 25 years of drug development and commercialization experience from one of the world's most successful pharmaceutical companies.
    2. Axcella has made impressive progress advancing its DAAC candidates for the multifunctional modulation of essential biological pathways into the clinic and is ready to enter an accelerated growth phase.
  3. Topics Mentioned